vs
ARROWHEAD PHARMACEUTICALS, INC.（ARWR）与DigitalOcean Holdings, Inc.（DOCN）财务数据对比。点击上方公司名可切换其他公司
ARROWHEAD PHARMACEUTICALS, INC.的季度营收约是DigitalOcean Holdings, Inc.的1.1倍（$264.0M vs $242.4M），ARROWHEAD PHARMACEUTICALS, INC.净利率更高（11.7% vs 10.6%，领先1.1%），ARROWHEAD PHARMACEUTICALS, INC.同比增速更快（10461.3% vs 18.3%），DigitalOcean Holdings, Inc.自由现金流更多（$31.1M vs $11.3M）
Arrowhead Pharmaceuticals是总部位于美国加利福尼亚州帕萨迪纳的上市生物制药企业，专注于通过RNA干扰（RNAi）作用机制开发创新药物，核心研发管线覆盖乙型肝炎、α-1抗胰蛋白酶缺陷相关肝病及心血管疾病的治疗领域。
DigitalOcean Holdings, Inc.是美国跨国科技企业及云服务提供商，总部位于美国科罗拉多州布鲁姆菲尔德，在全球布局15个数据中心，面向开发者、初创企业及中小微企业提供稳定易用的云基础设施即服务平台，助力各类技术团队高效开展业务。
ARWR vs DOCN — 直观对比
营收规模更大
ARWR
是对方的1.1倍
$242.4M
营收增速更快
ARWR
高出10443.0%
18.3%
净利率更高
ARWR
高出1.1%
10.6%
自由现金流更多
DOCN
多$19.8M
$11.3M
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $264.0M | $242.4M |
| 净利润 | $30.8M | $25.7M |
| 毛利率 | — | 58.7% |
| 营业利润率 | 15.5% | 16.0% |
| 净利率 | 11.7% | 10.6% |
| 营收同比 | 10461.3% | 18.3% |
| 净利润同比 | 117.8% | 40.5% |
| 每股收益（稀释后） | $0.22 | $0.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARWRDOCN
| Q4 25 | $264.0M | $242.4M | ||
| Q3 25 | — | $229.6M | ||
| Q2 25 | — | $218.7M | ||
| Q1 25 | — | $210.7M | ||
| Q4 24 | — | $204.9M | ||
| Q3 24 | — | $198.5M | ||
| Q2 24 | — | $192.5M | ||
| Q1 24 | — | $184.7M |
净利润ARWRDOCN
| Q4 25 | $30.8M | $25.7M | ||
| Q3 25 | — | $158.4M | ||
| Q2 25 | — | $37.0M | ||
| Q1 25 | — | $38.2M | ||
| Q4 24 | — | $18.3M | ||
| Q3 24 | — | $32.9M | ||
| Q2 24 | — | $19.1M | ||
| Q1 24 | — | $14.1M |
毛利率ARWRDOCN
| Q4 25 | — | 58.7% | ||
| Q3 25 | — | 59.6% | ||
| Q2 25 | — | 59.9% | ||
| Q1 25 | — | 61.4% | ||
| Q4 24 | — | 57.1% | ||
| Q3 24 | — | 60.2% | ||
| Q2 24 | — | 61.0% | ||
| Q1 24 | — | 60.7% |
营业利润率ARWRDOCN
| Q4 25 | 15.5% | 16.0% | ||
| Q3 25 | — | 19.6% | ||
| Q2 25 | — | 16.3% | ||
| Q1 25 | — | 17.9% | ||
| Q4 24 | — | 15.9% | ||
| Q3 24 | — | 12.4% | ||
| Q2 24 | — | 11.6% | ||
| Q1 24 | — | 6.2% |
净利率ARWRDOCN
| Q4 25 | 11.7% | 10.6% | ||
| Q3 25 | — | 69.0% | ||
| Q2 25 | — | 16.9% | ||
| Q1 25 | — | 18.1% | ||
| Q4 24 | — | 8.9% | ||
| Q3 24 | — | 16.6% | ||
| Q2 24 | — | 9.9% | ||
| Q1 24 | — | 7.7% |
每股收益（稀释后）ARWRDOCN
| Q4 25 | $0.22 | $0.23 | ||
| Q3 25 | — | $1.51 | ||
| Q2 25 | — | $0.39 | ||
| Q1 25 | — | $0.39 | ||
| Q4 24 | — | $0.21 | ||
| Q3 24 | — | $0.33 | ||
| Q2 24 | — | $0.20 | ||
| Q1 24 | — | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $715.0M | $254.5M |
| 总债务越低越好 | — | $1.3B |
| 股东权益账面价值 | $568.4M | $-28.7M |
| 总资产 | $1.6B | $1.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ARWRDOCN
| Q4 25 | $715.0M | $254.5M | ||
| Q3 25 | — | $236.6M | ||
| Q2 25 | — | $387.7M | ||
| Q1 25 | — | $360.4M | ||
| Q4 24 | — | $428.4M | ||
| Q3 24 | — | $439.9M | ||
| Q2 24 | — | $443.1M | ||
| Q1 24 | — | $419.1M |
总债务ARWRDOCN
| Q4 25 | — | $1.3B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ARWRDOCN
| Q4 25 | $568.4M | $-28.7M | ||
| Q3 25 | — | $-69.6M | ||
| Q2 25 | — | $-175.2M | ||
| Q1 25 | — | $-210.7M | ||
| Q4 24 | — | $-203.0M | ||
| Q3 24 | — | $-211.7M | ||
| Q2 24 | — | $-253.8M | ||
| Q1 24 | — | $-286.1M |
总资产ARWRDOCN
| Q4 25 | $1.6B | $1.8B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $1.7B | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | — | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.5M | $57.3M |
| 自由现金流经营现金流 - 资本支出 | $11.3M | $31.1M |
| 自由现金流率自由现金流/营收 | 4.3% | 12.8% |
| 资本支出强度资本支出/营收 | 0.8% | 10.8% |
| 现金转化率经营现金流/净利润 | 0.44× | 2.23× |
| 过去12个月自由现金流最近4个季度 | — | $180.5M |
8季度趋势，按日历期对齐
经营现金流ARWRDOCN
| Q4 25 | $13.5M | $57.3M | ||
| Q3 25 | — | $95.8M | ||
| Q2 25 | — | $92.4M | ||
| Q1 25 | — | $64.1M | ||
| Q4 24 | — | $71.3M | ||
| Q3 24 | — | $73.4M | ||
| Q2 24 | — | $71.3M | ||
| Q1 24 | — | $66.7M |
自由现金流ARWRDOCN
| Q4 25 | $11.3M | $31.1M | ||
| Q3 25 | — | $88.0M | ||
| Q2 25 | — | $59.3M | ||
| Q1 25 | — | $2.1M | ||
| Q4 24 | — | $26.1M | ||
| Q3 24 | — | $16.0M | ||
| Q2 24 | — | $39.5M | ||
| Q1 24 | — | $23.0M |
自由现金流率ARWRDOCN
| Q4 25 | 4.3% | 12.8% | ||
| Q3 25 | — | 38.3% | ||
| Q2 25 | — | 27.1% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 12.7% | ||
| Q3 24 | — | 8.1% | ||
| Q2 24 | — | 20.5% | ||
| Q1 24 | — | 12.5% |
资本支出强度ARWRDOCN
| Q4 25 | 0.8% | 10.8% | ||
| Q3 25 | — | 3.4% | ||
| Q2 25 | — | 15.2% | ||
| Q1 25 | — | 29.4% | ||
| Q4 24 | — | 22.1% | ||
| Q3 24 | — | 28.9% | ||
| Q2 24 | — | 16.6% | ||
| Q1 24 | — | 23.6% |
现金转化率ARWRDOCN
| Q4 25 | 0.44× | 2.23× | ||
| Q3 25 | — | 0.60× | ||
| Q2 25 | — | 2.50× | ||
| Q1 25 | — | 1.68× | ||
| Q4 24 | — | 3.91× | ||
| Q3 24 | — | 2.23× | ||
| Q2 24 | — | 3.73× | ||
| Q1 24 | — | 4.72× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARWR
暂无分部数据
DOCN
| Scalers | $84.3M | 35% |
| Scalers Plus | $69.9M | 29% |
| Builders | $64.1M | 26% |
| Learners Testers And Other | $24.1M | 10% |
